Renagel
Renagel (sevelamer hydrochloride) is a non-calcium, non-metal phosphate binder. It is used to treat hyperphosphatemia (high blood phosphorus levels) in adults with chronic kidney disease on hemodialysis. By binding dietary phosphorus in the gastrointestinal tract, it reduces phosphorus absorption into the bloodstream.
Dosage by Body Weight
Must be taken orally three times daily with meals. The initial dose typically ranges from 800 mg to 1600 mg per meal, depending on baseline serum phosphorus levels. Tablets must be swallowed whole; do not chew, crush, or break.
- Body Weight
- Below 5 kg
- Dose
- Not recommended
- Frequency
- N/A
- Tracking Notes
- Safety and efficacy have not been established in pediatric patients.
- Body Weight
- 5-7 kg
- Dose
- Not recommended
- Frequency
- N/A
- Tracking Notes
- Avoid use unless explicitly directed by a pediatric nephrologist.
- Body Weight
- 8-10 kg
- Dose
- Not recommended
- Frequency
- N/A
- Tracking Notes
- Not standardly dosed by weight; pediatric safety is not fully established.
- Body Weight
- 11-15 kg
- Dose
- Not routinely prescribed
- Frequency
- N/A
- Tracking Notes
- In pediatric populations, dosing is typically determined by body surface area (BSA) rather than weight.
- Body Weight
- 16-20 kg
- Dose
- Not routinely prescribed
- Frequency
- N/A
- Tracking Notes
- Consult a pediatric nephrologist. Efficacy and safety profiles are not established for this weight group.
| Body Weight | Dose | Frequency | Tracking Notes |
|---|---|---|---|
| Below 5 kg | Not recommended | N/A | Safety and efficacy have not been established in pediatric patients. |
| 5-7 kg | Not recommended | N/A | Avoid use unless explicitly directed by a pediatric nephrologist. |
| 8-10 kg | Not recommended | N/A | Not standardly dosed by weight; pediatric safety is not fully established. |
| 11-15 kg | Not routinely prescribed | N/A | In pediatric populations, dosing is typically determined by body surface area (BSA) rather than weight. |
| 16-20 kg | Not routinely prescribed | N/A | Consult a pediatric nephrologist. Efficacy and safety profiles are not established for this weight group. |
Formulation
Purpose
To control serum phosphorus levels in patients with chronic kidney disease (CKD) on dialysis.
Generic Name
Sevelamer hydrochlorideScheduled Drug
No. This medicine is generally not treated as a scheduled/prescription-only drug in common consumer references, but local rules may vary.